Walter I. Sussman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Walter I. Sussman has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Hirotaka Nakagawa
UC Davis Medical Center Sacramento California USA
6 shared publications David J. Park
Physical Medicine and Rehabilitation Resident, Tufts Medical Center, Boston, MA
3 shared publicationsErek Latzka
Department of Orthopedics and Rehabilitation Tufts Medical Center Boston Massachusetts USA
3 shared publicationsKen Mautner
Department of Physical Medicine and Rehabilitation Emory University School of Medicine Atlanta Georgia USA
3 shared publicationsKyungje Sung
Orthopedics & Sports Medicine, Kettering Health Network, Kettering, OH
3 shared publications- Ryan C. Kruse
Department of Orthopedics and Rehabilitation, University of Iowa Sports Medicine, Iowa City, Iowa
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 19 (1) , 69
Sonographic Evaluation of Plantar Hindfoot Pain in Athletes
Purpose of Review: To provide an anatomy-based review of musculoskeletal ultrasound (US) in the evaluation of plantar hindfoot pain in athletes. This review summarizes normal sonographic anatomy, characteristic findings, diagnostic utility, and limitations for plantar fascia, heel fat pad, calcaneal, peripheral nerve, vascular, and foreign-body pathology. It also examines how US findings should be integrated with the history and physical examination in athletes. Recent Findings: Recent studies support high-resolution, dynamic US as a useful imaging modality for plantar hindfoot pain. US enables real-time assessment, contralateral comparison, sonopalpation, and evaluation during dynamic maneuvers. Emerging literature has further characterized the layered structure and loading behavior of the heel fat pad, dynamic sonographic findings of fat pad fracture and subluxation, and assessment of peripheral nerve entrapment. Recent studies also demonstrate that plantar fascia, heel fat pad, and other hindfoot abnormalities are prevalent in asymptomatic athletes. Although sonographic abnormalities may be associated with future time-loss injury, their low positive predictive value limits their role as a screening tool. MRI remains important when evaluating suspected calcaneal stress injury, marrow pathology, or complex soft-tissue disease. Summary: US is an accessible and valuable modality for the assessment of plantar heel pain in athletes. A structured, symptom-driven examination may improve diagnostic precision and identify alternative or coexisting pathology. Sonographic findings should be correlated with symptom location, physical examination, and sonopalpatory pain, particularly because structural abnormalities are common in asymptomatic athletes.
- 21 October 2026
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 19 (1) , 69
Open AccessSonographic Evaluation of Plantar Hindfoot Pain in Athletes
Purpose of Review: To provide an anatomy-based review of musculoskeletal ultrasound (US) in the evaluation of plantar hindfoot pain in athletes. This review summarizes normal sonographic anatomy, characteristic findings, diagnostic utility, and limitations for plantar fascia, heel fat pad, calcaneal, peripheral nerve, vascular, and foreign-body pathology. It also examines how US findings should be integrated with the history and physical examination in athletes. Recent Findings: Recent studies support high-resolution, dynamic US as a useful imaging modality for plantar hindfoot pain. US enables real-time assessment, contralateral comparison, sonopalpation, and evaluation during dynamic maneuvers. Emerging literature has further characterized the layered structure and loading behavior of the heel fat pad, dynamic sonographic findings of fat pad fracture and subluxation, and assessment of peripheral nerve entrapment. Recent studies also demonstrate that plantar fascia, heel fat pad, and other hindfoot abnormalities are prevalent in asymptomatic athletes. Although sonographic abnormalities may be associated with future time-loss injury, their low positive predictive value limits their role as a screening tool. MRI remains important when evaluating suspected calcaneal stress injury, marrow pathology, or complex soft-tissue disease. Summary: US is an accessible and valuable modality for the assessment of plantar heel pain in athletes. A structured, symptom-driven examination may improve diagnostic precision and identify alternative or coexisting pathology. Sonographic findings should be correlated with symptom location, physical examination, and sonopalpatory pain, particularly because structural abnormalities are common in asymptomatic athletes.
Assessment of adverse events and safety associated with intra‐articular platelet‐rich plasma injections compared to other injectates for knee osteoarthritis: A systematic review and meta‐analysis
Objective: To evaluate adverse events (AEs) associated with intra‐articular platelet‐rich plasma (IA‐PRP) injections for knee osteoarthritis (KOA) and compare their rates with those of intra‐articular corticosteroids (IA‐CS), hyaluronic acid (IA‐HA), and normal saline (IA‐NS). Literature Survey: A systematic search of PubMed, Embase, and Cochrane Library databases identified randomized controlled trials (RCTs) published after 2015. Studies were included if they reported AEs related to IA‐PRP injections for KOA and provided comparator data for IA‐CS, IA‐HA, or IA‐NS. Methodology: Data on AEs were extracted and categorized into mild knee pain and swelling, severe knee pain requiring withdrawal, knee stiffness, other musculoskeletal (MSK) events, non‐MSK events, and severe AEs. A random‐effects meta‐analysis was performed to calculate odds ratios (OR) with 95% confidence intervals (CI) for AE rates in IA‐PRP versus comparator groups. Subgroup analysis was conducted to evaluate the effects of leukocyte concentration on AE rates. Synthesis: Thirty‐two RCTs published articles, involving 1268 IA‐PRP‐treated knees, met inclusion criteria. AEs were reported in 18.7% of IA‐PRP cases, with mild knee pain and swelling being the most common (10.6%). Compared to IA‐HA, IA‐PRP had significantly higher rates of mild knee pain and swelling ( p < .001). Subgroup analysis revealed that this difference was significant only for leukocyte‐rich IA‐PRP ( p < .05), whereas leukocyte‐poor IA‐PRP showed no significant difference compared to IA‐HA ( p = .51). Knee stiffness was more frequent in IA‐PRP versus IA‐NS ( p = .031). There were no significant differences in other AE categories, and no severe AEs were reported across any groups. Conclusions: IA‐PRP injections are associated with mild, transient AEs such as knee pain and swelling, particularly with leukocyte‐rich PRP formulations. These symptoms typically resolve without intervention. Leukocyte‐poor IA‐PRP showed a similar safety profile to IA‐HA. No severe AEs were observed, supporting the overall safety of IA‐PRP for KOA. Clinicians should counsel patients on the likelihood of mild postprocedure symptoms, especially with high leukocyte formulations, while considering IA‐PRP as a treatment option.
Assessment of adverse events and safety associated with intra‐articular platelet‐rich plasma injections compared to other injectates for knee osteoarthritis: A systematic review and meta‐analysis
Objective: To evaluate adverse events (AEs) associated with intra‐articular platelet‐rich plasma (IA‐PRP) injections for knee osteoarthritis (KOA) and compare their rates with those of intra‐articular corticosteroids (IA‐CS), hyaluronic acid (IA‐HA), and normal saline (IA‐NS). Literature Survey: A systematic search of PubMed, Embase, and Cochrane Library databases identified randomized controlled trials (RCTs) published after 2015. Studies were included if they reported AEs related to IA‐PRP injections for KOA and provided comparator data for IA‐CS, IA‐HA, or IA‐NS. Methodology: Data on AEs were extracted and categorized into mild knee pain and swelling, severe knee pain requiring withdrawal, knee stiffness, other musculoskeletal (MSK) events, non‐MSK events, and severe AEs. A random‐effects meta‐analysis was performed to calculate odds ratios (OR) with 95% confidence intervals (CI) for AE rates in IA‐PRP versus comparator groups. Subgroup analysis was conducted to evaluate the effects of leukocyte concentration on AE rates. Synthesis: Thirty‐two RCTs published articles, involving 1268 IA‐PRP‐treated knees, met inclusion criteria. AEs were reported in 18.7% of IA‐PRP cases, with mild knee pain and swelling being the most common (10.6%). Compared to IA‐HA, IA‐PRP had significantly higher rates of mild knee pain and swelling ( p < .001). Subgroup analysis revealed that this difference was significant only for leukocyte‐rich IA‐PRP ( p < .05), whereas leukocyte‐poor IA‐PRP showed no significant difference compared to IA‐HA ( p = .51). Knee stiffness was more frequent in IA‐PRP versus IA‐NS ( p = .031). There were no significant differences in other AE categories, and no severe AEs were reported across any groups. Conclusions: IA‐PRP injections are associated with mild, transient AEs such as knee pain and swelling, particularly with leukocyte‐rich PRP formulations. These symptoms typically resolve without intervention. Leukocyte‐poor IA‐PRP showed a similar safety profile to IA‐HA. No severe AEs were observed, supporting the overall safety of IA‐PRP for KOA. Clinicians should counsel patients on the likelihood of mild postprocedure symptoms, especially with high leukocyte formulations, while considering IA‐PRP as a treatment option.
AAPM &R guidance statement on platelet rich plasma for knee osteoarthritis
Background: The current nonoperative standard‐of‐care therapies for knee osteoarthritis (OA) include weight reduction, physical therapy, analgesics, optimization of biomechanics, and intra‐articular injection of corticosteroids. Platelet rich plasma (PRP) is an orthobiologic intervention that is increasingly used in patients with knee OA, primarily due to its many key mediators that can potentially reduce joint inflammation thereby improving pain and enhancing overall joint function. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) convened a technical expert panel (TEP) to summarize and assess the evidence for use of PRP in patients with knee OA and synthesize current knowledge into a summary document that can serve as a resource for clinicians. We address many of the questions and decision points that practitioners need to consider for responsible use of PRP in knee OA. Objective: To develop consensus‐based practice recommendations to identify and address gaps in PRP applications in patients with knee OA. Methods: The AAPM&R orthobiologic TEP initiated development of this consensus guidance statement in March 2023. The TEP was responsible for formulating search terms and research questions and synthesizing evidence obtained from a structured literature review that was initially completed in April 2023 and subsequently updated to reflect studies published between May 2023 and June 2025. The recommended actions and best practices in this guidance reflect consensus being achieved by the expert physiatrists and supported by best available evidence, where available. These actions and practices were conceptualized in response to common questions this expert panel frequently encounter in the use and administration of PRP. The TEP was asked to consider the strengths and limitations of available evidence and augment with expert opinion focused on closing knowledge gaps guiding the delivery of PRP in patients with knee OA. Results: As a result of the structured literature review and use of a modified Delphi process to achieve consensus on clinical guidance for PRP use in patients with knee OA, the AAPM&R TEP on use of PRP in knee OA arrived at five evidence‐based clinical recommendations for PRP management and 11 consensus‐based best practices supported by expert opinion and limited evidence. Conclusion: This consensus guidance addresses common questions about the use of PRP in patients with knee OA and provides actionable recommendations and best practices based on expert opinion supported by best available evidence. Despite their growing availability as point‐of‐care interventions, orthobiologic therapies remain an evolving area of practice. Robust, dose‐dependent randomized controlled trials are needed to more clearly establish the clinical effects of PRP on patient outcomes. Clinical judgment should be exercised and management options tailored to individual patient needs, preferences, and risk profiles.
AAPM &R guidance statement on platelet rich plasma for knee osteoarthritis
Background: The current nonoperative standard‐of‐care therapies for knee osteoarthritis (OA) include weight reduction, physical therapy, analgesics, optimization of biomechanics, and intra‐articular injection of corticosteroids. Platelet rich plasma (PRP) is an orthobiologic intervention that is increasingly used in patients with knee OA, primarily due to its many key mediators that can potentially reduce joint inflammation thereby improving pain and enhancing overall joint function. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) convened a technical expert panel (TEP) to summarize and assess the evidence for use of PRP in patients with knee OA and synthesize current knowledge into a summary document that can serve as a resource for clinicians. We address many of the questions and decision points that practitioners need to consider for responsible use of PRP in knee OA. Objective: To develop consensus‐based practice recommendations to identify and address gaps in PRP applications in patients with knee OA. Methods: The AAPM&R orthobiologic TEP initiated development of this consensus guidance statement in March 2023. The TEP was responsible for formulating search terms and research questions and synthesizing evidence obtained from a structured literature review that was initially completed in April 2023 and subsequently updated to reflect studies published between May 2023 and June 2025. The recommended actions and best practices in this guidance reflect consensus being achieved by the expert physiatrists and supported by best available evidence, where available. These actions and practices were conceptualized in response to common questions this expert panel frequently encounter in the use and administration of PRP. The TEP was asked to consider the strengths and limitations of available evidence and augment with expert opinion focused on closing knowledge gaps guiding the delivery of PRP in patients with knee OA. Results: As a result of the structured literature review and use of a modified Delphi process to achieve consensus on clinical guidance for PRP use in patients with knee OA, the AAPM&R TEP on use of PRP in knee OA arrived at five evidence‐based clinical recommendations for PRP management and 11 consensus‐based best practices supported by expert opinion and limited evidence. Conclusion: This consensus guidance addresses common questions about the use of PRP in patients with knee OA and provides actionable recommendations and best practices based on expert opinion supported by best available evidence. Despite their growing availability as point‐of‐care interventions, orthobiologic therapies remain an evolving area of practice. Robust, dose‐dependent randomized controlled trials are needed to more clearly establish the clinical effects of PRP on patient outcomes. Clinical judgment should be exercised and management options tailored to individual patient needs, preferences, and risk profiles.
Adipose‐derived mechanically processed tissue in orthopedics: A call for a standard classification system
Adipose‐derived cellular therapies (AD‐CTs) are increasingly used in orthopedics, yet the field lacks a standardized framework for classifying these heterogeneous products. Although prior efforts have standardized platelet‐rich plasma and bone marrow‐derived mesenchymal stromal cells, AD preparations remain inconsistently defined and poorly characterized. AD‐CTs encompass a range of products including enzymatically derived stromal vascular fraction, culture‐expanded adipose‐derived mesenchymal stromal cells (AD‐MSCs), and mechanically processed adipose tissue (AD‐MPT),each with distinct regulatory, cellular, and structural profiles. Unlike stromal vascular fraction and AD‐MSCs, which can be quantified using conventional assays, the intact extracellular matrix in AD‐MPTs complicates objective characterization. This paper introduces the Mechanical Processing (Harvesting) of Adipose Tissue classification system as a novel framework for standardizing the reporting of AD‐MPT harvesting and processing techniques that provides a structured approach to nomenclature and reporting. The system aims to enhance study comparability, facilitate research replication, and support the responsible advancement of adipose‐based therapies in musculoskeletal medicine.
Adipose‐derived mechanically processed tissue in orthopedics: A call for a standard classification system
Adipose‐derived cellular therapies (AD‐CTs) are increasingly used in orthopedics, yet the field lacks a standardized framework for classifying these heterogeneous products. Although prior efforts have standardized platelet‐rich plasma and bone marrow‐derived mesenchymal stromal cells, AD preparations remain inconsistently defined and poorly characterized. AD‐CTs encompass a range of products including enzymatically derived stromal vascular fraction, culture‐expanded adipose‐derived mesenchymal stromal cells (AD‐MSCs), and mechanically processed adipose tissue (AD‐MPT),each with distinct regulatory, cellular, and structural profiles. Unlike stromal vascular fraction and AD‐MSCs, which can be quantified using conventional assays, the intact extracellular matrix in AD‐MPTs complicates objective characterization. This paper introduces the Mechanical Processing (Harvesting) of Adipose Tissue classification system as a novel framework for standardizing the reporting of AD‐MPT harvesting and processing techniques that provides a structured approach to nomenclature and reporting. The system aims to enhance study comparability, facilitate research replication, and support the responsible advancement of adipose‐based therapies in musculoskeletal medicine.
- 18 February 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (5) , 370-378
Effects of percutaneous platelet-rich plasma injection on return-to-play after acute hamstring muscle injury: a systematic review and meta-analysis
Objective: To evaluate the effectiveness and safety of platelet-rich plasma (PRP) for acute hamstring injuries, with attention to return-to-play (RTP) time, reinjury rates and adverse events. Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). Risk of bias was assessed using the Cochrane tool; certainty of evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). Data sources: Databases included Embase, MEDLINE, Web of Science, Elsevier and Cochrane Central searched through March 2025. Eligibility criteria: RCTs comparing PRP to control treatments for acute hamstring injuries were included. Non-randomised and chronic tendinopathy studies were excluded. Results: Six RCTs (n=277) were included. PRP reduced RTP time versus control (mean difference –8.6 days; 21.4 vs 30.0 days; 95% CI –3.04 to –0.03; p=0.045), though heterogeneity was high (I²=94.1%). Reinjury (15% vs 16%; p=0.722) and adverse event rates (1% vs 0%; p=0.687) did not differ. Certainty of evidence was rated as low to moderate due to risk of bias and imprecision. Conclusion: PRP may shorten RTP in acute hamstring injuries, especially when image-guided. Reinjury risk appears unchanged. Further trials are needed to confirm these findings and standardise biological use in muscle injuries. PROSPERO registration number: CRD420251109346.
- 18 February 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (5) , 370-378
Effects of percutaneous platelet-rich plasma injection on return-to-play after acute hamstring muscle injury: a systematic review and meta-analysis
Objective: To evaluate the effectiveness and safety of platelet-rich plasma (PRP) for acute hamstring injuries, with attention to return-to-play (RTP) time, reinjury rates and adverse events. Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). Risk of bias was assessed using the Cochrane tool; certainty of evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). Data sources: Databases included Embase, MEDLINE, Web of Science, Elsevier and Cochrane Central searched through March 2025. Eligibility criteria: RCTs comparing PRP to control treatments for acute hamstring injuries were included. Non-randomised and chronic tendinopathy studies were excluded. Results: Six RCTs (n=277) were included. PRP reduced RTP time versus control (mean difference –8.6 days; 21.4 vs 30.0 days; 95% CI –3.04 to –0.03; p=0.045), though heterogeneity was high (I²=94.1%). Reinjury (15% vs 16%; p=0.722) and adverse event rates (1% vs 0%; p=0.687) did not differ. Certainty of evidence was rated as low to moderate due to risk of bias and imprecision. Conclusion: PRP may shorten RTP in acute hamstring injuries, especially when image-guided. Reinjury risk appears unchanged. Further trials are needed to confirm these findings and standardise biological use in muscle injuries. PROSPERO registration number: CRD420251109346.
- 4 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
Sonographic Features of Shoulder Injury Related to Vaccine Administration: A Case Series
This case series describes five patients with persistent shoulder pain and dysfunction consistent with Shoulder Injury Related to Vaccine Administration. All the patients here had a distinct sonographic pattern of multiple punctate hyperechoic foci within the rotator cuff (RC) tendons. These abnormal foci were confirmed to be a pain generator using an ultrasound-guided diagnostic anesthetic injections, and each patient underwent a successful tenotomy, vacuum aspiration, and debridement of these lesions. Ultrasound findings of vaccine-induced reactive changes within the RC have not been previously reported, and the sonographic findings presented in this case series are distinct from the findings traditionally seen in degenerative tendinopathy or acute RC tears. Identification of this pattern and confirmatory anesthetic injection may aid in the diagnosis of Shoulder Injury Related to Vaccine Administration and guide minimally invasive treatments in chronic cases unresponsive to conservative management.
- 4 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
Sonographic Features of Shoulder Injury Related to Vaccine Administration: A Case Series
This case series describes five patients with persistent shoulder pain and dysfunction consistent with Shoulder Injury Related to Vaccine Administration. All the patients here had a distinct sonographic pattern of multiple punctate hyperechoic foci within the rotator cuff (RC) tendons. These abnormal foci were confirmed to be a pain generator using an ultrasound-guided diagnostic anesthetic injections, and each patient underwent a successful tenotomy, vacuum aspiration, and debridement of these lesions. Ultrasound findings of vaccine-induced reactive changes within the RC have not been previously reported, and the sonographic findings presented in this case series are distinct from the findings traditionally seen in degenerative tendinopathy or acute RC tears. Identification of this pattern and confirmatory anesthetic injection may aid in the diagnosis of Shoulder Injury Related to Vaccine Administration and guide minimally invasive treatments in chronic cases unresponsive to conservative management.
- Open Access
- 24 December 2025
- Published by Elsevier in Journal of Hand Surgery Global Online
- Vol. 8 (2) , 100903
The Reversed Palmaris Longus: Sonographic Findings and Anatomical Correlation With Implications for Carpal Tunnel Syndrome Diagnosis and Management
- 24 December 2025
- Published by Elsevier in Journal of Hand Surgery Global Online
- Vol. 8 (2) , 100903
Open AccessThe Reversed Palmaris Longus: Sonographic Findings and Anatomical Correlation With Implications for Carpal Tunnel Syndrome Diagnosis and Management
- Open Access
- 7 August 2025
- Published by Elsevier in Interventional Pain Medicine
- Vol. 4 (3) , 100619
Concerns regarding Palee et al. and reasserting the underlying mechanism of action in percutaneous tenotomy
- 7 August 2025
- Published by Elsevier in Interventional Pain Medicine
- Vol. 4 (3) , 100619
Open AccessConcerns regarding Palee et al. and reasserting the underlying mechanism of action in percutaneous tenotomy